Standout Papers

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs 2020 2026 2022 2024439
  1. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs (2020)
    Sangeun Jeon, Meehyun Ko et al. Antimicrobial Agents and Chemotherapy

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 52 standout
Sub-graph 1 of 24

Citing Papers

Long COVID: a clinical update
2024 Standout
Targeted protein degradation: from mechanisms to clinic
2024 Standout
2 intermediate papers

Works of David Shum being referenced

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
2021
Next-Generation Phenotypic Screening in Early Drug Discovery for Infectious Diseases
2019

Author Peers

Author Last Decade Papers Cites
David Shum 489 328 191 44 1.1k
Karine Alvarez 643 510 101 46 1.3k
Christin Müller 366 398 229 35 972
Shibo Jiang 586 473 291 53 1.4k
Yanchen Zhou 566 215 131 29 1.2k
Eva Žusinaite 438 253 143 44 891
Cristiano Salata 488 326 333 59 1.3k
Ilaria Vicenti 656 120 212 73 909
K Stenberg 201 250 438 40 1.1k
Rana Abdelnabi 865 229 212 48 1.3k
Kornelia Hardes 693 386 202 39 1.3k

All Works

Loading papers...

Rankless by CCL
2026